Candida tropicalis biofilm inhibition by ZnO nanoparticles and EDTA.

[1]  P. Karmakar,et al.  Differential toxicity of rod and spherical zinc oxide nanoparticles on human peripheral blood mononuclear cells. , 2014, Journal of biomedical nanotechnology.

[2]  G. N. Rao,et al.  Synthesis, characterization and optical properties of zinc oxide nanoparticles , 2013, International Nano Letters.

[3]  A. Srinivasan,et al.  Effects of Fluconazole, Amphotericin B, and Caspofungin on Candida albicans Biofilms under Conditions of Flow and on Biofilm Dispersion , 2011, Antimicrobial Agents and Chemotherapy.

[4]  David W Williams,et al.  Candida biofilms and oral candidosis: treatment and prevention. , 2011, Periodontology 2000.

[5]  Lutz Mädler,et al.  Stability, bioavailability, and bacterial toxicity of ZnO and iron-doped ZnO nanoparticles in aquatic media. , 2011, Environmental science & technology.

[6]  M. Fontaine‐Aupart,et al.  Diffusion of Nanoparticles in Biofilms Is Altered by Bacterial Cell Wall Hydrophobicity , 2010, Applied and Environmental Microbiology.

[7]  J. A. Ferreira,et al.  Biofilm Formation and Effect of Caspofungin on Biofilm Structure of Candida Species Bloodstream Isolates , 2009, Antimicrobial Agents and Chemotherapy.

[8]  M. Singla,et al.  Optical characterization of ZnO nanoparticles capped with various surfactants , 2009 .

[9]  D. Kontoyiannis,et al.  Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm. , 2008, International journal of antimicrobial agents.

[10]  Subcommittee on Antifungal Susceptibility Testing.  EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  Cheng-Hsien Hsieh.  Spherical Zinc Oxide Nano Particles from Zinc Acetate in the Precipitation Method , 2007 .

[12]  A. Watanabe,et al.  Antifungal effects of a tissue conditioner coating agent with TiO2 photocatalyst. , 2005, Journal of medical and dental sciences.

[13]  R. Donlan,et al.  Tetrasodium EDTA as a Novel Central Venous Catheter Lock Solution Against Biofilm , 2005, Infection Control & Hospital Epidemiology.

[14]  P. D. Rogers,et al.  Antifungal agents: methods and protocols. , 2005 .

[15]  B. Tyler,et al.  Adhesion and biofilm formation of Candida albicans on native and pluronic-treated polystyrene , 2005 .

[16]  R. Darouiche,et al.  Candida Infections of Medical Devices , 2004, Clinical Microbiology Reviews.

[17]  Paul Stoodley,et al.  Bacterial biofilms: from the Natural environment to infectious diseases , 2004, Nature Reviews Microbiology.

[18]  M. Jabra-Rizk,et al.  Fungal Biofilms and Drug Resistance , 2004, Emerging infectious diseases.

[19]  J. Oxford,et al.  Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  W. Dunne,et al.  Bacterial Adhesion: Seen Any Good Biofilms Lately? , 2002, Clinical Microbiology Reviews.

[21]  J. Thornby,et al.  Risk Factors for Candida tropicalis fungemia in patients with cancer. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  S. Haile,et al.  Aqueous Precipitation of Spherical Zinc Oxide Powders for Varistor Applications , 1989 .

[23]  J. W. Hastings,et al.  BIOLUMINESCENCE AND CHEMILUMINESCENCE , 1976, Photochemistry and photobiology.

[24]  C. P. Lamar.  Chelation Therapy of Occlusive Arteriosclerosis in Diabetic Patients , 1964, Angiology.